FBXO7 and Parkinson disease: In summary, we identified 338 new targets of SCFFbxo7 using a high-throughput, cell-independent proteomic approach and validated Gsk3β and Tomm20 as new substrates, and argue against defective regulation of Tomm20 by Fbxo7 as an underlying mechanism in PD.